C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women

International Journal of Obesity

Volumn 25, Issue 10, 2001, Pages 1416-1420

  Pannacciulli, N ^a   Cantatore, F P ^a   Minenna, A ^a   Bellacicco, M ^a   Giorgino, R ^a   De Pergola, G ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Body composition; C reactive protein; Central fat; Insulin resistance; Total body fat

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANTHROPOMETRY; ARTICLE; ATHEROGENESIS; BODY COMPOSITION; BODY FAT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HOMEOSTASIS; HUMAN; IMPEDANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ABDOMEN; ADIPOSE TISSUE; ADOLESCENT; ADULT; AGE FACTORS; ANTHROPOMETRY; ARTERIOSCLEROSIS; BODY COMPOSITION; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; ELECTRIC IMPEDANCE; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY;

EID: 0034769085     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801719     Document Type: Article

References (33)

1. The acute-phase response and C-reactive protein
2. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
3. Plasma concentration of C-reactive protein and the risk of developing peripheral vascular disease
4. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men
5. C-reactive protein: Binding to lipids and lipoproteins
6. Complement activation by C-reactive protein complexes
7. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor
8. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men
9. Elevated C-reactive protein levels in overweight and obese adults
10. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance
11. Aromatase activity and interleukin-6 production by normal and malignant breast tissue
12. The acute-phase response
13. The pathophysiologic roles of interleukin-6 in human disease
14. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction
15. Homeostatic model assessment: Insulin resistance and β-cell function from fasting glucose and insulin concentrations in man
16. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
17. Prediction of body water and fat in adult Danes from measurement of electrical impedance. A validation study
18. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
19. Health implications of obesity
20. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men
21. Body mass index, waist/hip ratio, and coronary heart disease incidence in African-Americans and whites
22. Relationship of abdominal obesity and hyperinsulinemia to angiographically assessed coronary artery disease in men with known mutations in the LDL receptor gene
23. The insulin resistance-dyslipidemic syndrome of visceral obesity: Effect on patients' risk
24. Relationship of visceral adipose tissue to metabolic risk factors for coronary heart disease: Is there a contribution of subcutaneous fat cell hypertrophy?
25. Obesity and cardiovascular diseases
26. C-reactive protein and its relation to cardiovascular risk factors
27. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly
28. Relation of the white blood cell count to obesity and insulin resistance: Effect of race and gender
29. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6
30. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance
31. The role of TNF alpha and TNF receptors in obesity and insulin resistance
32. Mechanisms of TNF-alpha-induced insulin resistance
33. Chronic subclinical inflammation as part of insulin resistance syndrome: The insulin resistance atherosclerosis study